Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1995 Jun;39(6):641–649.

Amlodipine induces a flow and pressure-independent vasoactive effect on the brachial artery in hypertension.

J L Megnien 1, J Levenson 1, M Del-Pino 1, A Simon 1
PMCID: PMC1365076  PMID: 7654482

Abstract

1. The objectives of this study were to study the flow-dependent arterial reactivity and pressure-independent arterial compliance of the calcium antagonist amlodipine in hypertensive men. 2. Twenty-one hypertensive patients were randomized to receive 2 months treatment with placebo (n = 10) or 5-10 mg amlodipine (n = 11) once a day. Non-invasive measurement of brachial artery mean blood pressure, diameter and flow (pulsed Doppler) and compliance (arterial mechanography and logarithmic elastic model) were obtained before and after drug administration. Vasoreactivity was studied by means of response of the brachial artery during exclusion of the hand and hyperaemia post-ischaemia. 3. Compared with placebo, amlodipine reduced mean blood pressure (% change +/- s.e. mean 11 +/- 1% vs 4 +/- 3%, P < 0.05), and increased arterial compliance at prevailing pressure (44 +/- 13%, vs 1 +/- 8%, P < 0.05) and at isobaric pressure (26 +/- 10% vs -3 +/- 6%, P < 0.05). A significant % change increase from baseline in brachial artery diameter between placebo and amlodipine was observed at rest (-2 +/- 3 vs 8 +/- 3%; P < 0.05), after wrist occlusion (-3 +/- 3 vs 6 +/- 2%; P < 0.05) and during reactive hyperaemia (-5 +/- 3 vs 18 +/- 5%; P < 0.05). No significant differences between amlodipine and placebo groups were observed in blood velocity after forearm manoeuvres before and after treatment. 4. No differences were observed between groups in brachial flow-dependent vasodilation.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
641

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abernethy D. R., Gutkowska J., Winterbottom L. M. Effects of amlodipine, a long-acting dihydropyridine calcium antagonist in aging hypertension: pharmacodynamics in relation to disposition. Clin Pharmacol Ther. 1990 Jul;48(1):76–86. doi: 10.1038/clpt.1990.120. [DOI] [PubMed] [Google Scholar]
  2. Anderson E. A., Mark A. L. Flow-mediated and reflex changes in large peripheral artery tone in humans. Circulation. 1989 Jan;79(1):93–100. doi: 10.1161/01.cir.79.1.93. [DOI] [PubMed] [Google Scholar]
  3. Armentano R., Simon A., Levenson J., Chau N. P., Megnien J. L., Pichel R. Mechanical pressure versus intrinsic effects of hypertension on large arteries in humans. Hypertension. 1991 Nov;18(5):657–664. doi: 10.1161/01.hyp.18.5.657. [DOI] [PubMed] [Google Scholar]
  4. Bernini F., Catapano A. L., Corsini A., Fumagalli R., Paolétti R. Effects of calcium antagonists on lipids and atherosclerosis. Am J Cardiol. 1989 Nov 7;64(17):129I–134I. doi: 10.1016/0002-9149(89)90970-3. [DOI] [PubMed] [Google Scholar]
  5. Calver A., Collier J., Moncada S., Vallance P. Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens. 1992 Sep;10(9):1025–1031. [PubMed] [Google Scholar]
  6. Chau N. P., Simon A., Vilar J., Cabrera-Fischer E., Pithois-Merli I., Levenson J. Active and passive effects of antihypertensive drugs on large artery diameter and elasticity in human essential hypertension. J Cardiovasc Pharmacol. 1992 Jan;19(1):78–85. doi: 10.1097/00005344-199201000-00011. [DOI] [PubMed] [Google Scholar]
  7. Chichester C. O., Rodgers R. L. Effects of doxazosin on vascular collagen synthesis, arterial pressure and serum lipids in the spontaneously hypertensive rat. J Cardiovasc Pharmacol. 1987;10 (Suppl 9):S21–S26. [PubMed] [Google Scholar]
  8. Filitti V., Giral P., Simon A., Merli I., Del Pino M., Levenson J. Enhanced constriction of the peripheral large artery in response to acute induction of a low-flow state in human hypercholesterolemia. Arterioscler Thromb. 1991 Jan-Feb;11(1):161–166. doi: 10.1161/01.atv.11.1.161. [DOI] [PubMed] [Google Scholar]
  9. Fleckenstein A., Frey M., Zorn J., Fleckenstein-Grün G. Amlodipine, a new 1,4-dihydropyridine calcium antagonist with a particularly strong antihypertensive profile. Am J Cardiol. 1989 Nov 7;64(17):21I–34I. doi: 10.1016/0002-9149(89)90957-0. [DOI] [PubMed] [Google Scholar]
  10. Gariepy J., Massonneau M., Levenson J., Heudes D., Simon A. Evidence for in vivo carotid and femoral wall thickening in human hypertension. Groupe de Prévention Cardio-vasculaire en Médecine du Travail. Hypertension. 1993 Jul;22(1):111–118. doi: 10.1161/01.hyp.22.1.111. [DOI] [PubMed] [Google Scholar]
  11. Hallock P., Benson I. C. STUDIES ON THE ELASTIC PROPERTIES OF HUMAN ISOLATED AORTA. J Clin Invest. 1937 Jul;16(4):595–602. doi: 10.1172/JCI100886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hayoz D., Tardy Y., Perret F., Waeber B., Meister J. J., Brunner H. R. Non-invasive determination of arterial diameter and distensibility by echo-tracking techniques in hypertension. J Hypertens Suppl. 1992 Jul;10(5):S95–100. [PubMed] [Google Scholar]
  13. Hirai T., Sasayama S., Kawasaki T., Yagi S. Stiffness of systemic arteries in patients with myocardial infarction. A noninvasive method to predict severity of coronary atherosclerosis. Circulation. 1989 Jul;80(1):78–86. doi: 10.1161/01.cir.80.1.78. [DOI] [PubMed] [Google Scholar]
  14. Inoue T., Tomoike H., Hisano K., Nakamura M. Endothelium determines flow-dependent dilation of the epicardial coronary artery in dogs. J Am Coll Cardiol. 1988 Jan;11(1):187–191. doi: 10.1016/0735-1097(88)90188-x. [DOI] [PubMed] [Google Scholar]
  15. Levenson J. A., Peronneau P. A., Simon A., Safar M. E. Pulsed Doppler: determination of diameter, blood flow velocity, and volumic flow of brachial artery in man. Cardiovasc Res. 1981 Mar;15(3):164–170. doi: 10.1093/cvr/15.3.164. [DOI] [PubMed] [Google Scholar]
  16. Levenson J., Simon A. C., Bouthier J., Maarek B. C., Safar M. E. The effect of acute and chronic nicardipine therapy on forearm arterial haemodynamics in essential hypertension. Br J Clin Pharmacol. 1985;20 (Suppl 1):107S–113S. doi: 10.1111/j.1365-2125.1985.tb05151.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Levenson J., Simon A. C., Safar M. E., Bouthier J., Maarek B. C. Large arteries in hypertension: acute effects of a new calcium entry blocker, nitrendipine. J Cardiovasc Pharmacol. 1984;6 (Suppl 7):S1006–S1010. [PubMed] [Google Scholar]
  18. Levenson J., Simon A. Heterogeneity of response of peripheral arteries to antihypertensive drugs in essential hypertension. Basic effects and functional consequences. Drugs. 1988;35 (Suppl 5):34–39. doi: 10.2165/00003495-198800355-00005. [DOI] [PubMed] [Google Scholar]
  19. Levenson J., Simon A., Pithois-Merli I. Brachial arterial changes in response to wrist occlusion in normotensive and hypertensive men. Am J Physiol. 1987 Aug;253(2 Pt 2):H217–H224. doi: 10.1152/ajpheart.1987.253.2.H217. [DOI] [PubMed] [Google Scholar]
  20. Lund-Johansen P., Omvik P., White W., Digranes O., Helland B., Jordal O., Stray T. Long-term haemodynamic effects of amlodipine at rest and during exercise in essential hypertension. J Hypertens. 1990 Dec;8(12):1129–1136. doi: 10.1097/00004872-199012000-00009. [DOI] [PubMed] [Google Scholar]
  21. Lyons D., Webster J., Benjamin N. The effect of antihypertensive therapy on responsiveness to local intra-arterial NG-monomethyl-L-arginine in patients with essential hypertension. J Hypertens. 1994 Sep;12(9):1047–1052. [PubMed] [Google Scholar]
  22. Maruyama M., Kamiya J., Kaiho T., Kobari T. Cardiovascular properties of MS-857, a new and potent cardiotonic agent, on normal and failing hearts. J Cardiovasc Pharmacol. 1988;12(5):579–586. doi: 10.1097/00005344-198811000-00012. [DOI] [PubMed] [Google Scholar]
  23. Merli I., Simon A., Del Pino M., Brautigam M., Welzel D., Levenson J. Intrinsic effect of antihypertensive treatment with isradipine and metoprolol on large artery geometric and elastic properties. Clin Pharmacol Ther. 1993 Jul;54(1):76–83. doi: 10.1038/clpt.1993.114. [DOI] [PubMed] [Google Scholar]
  24. Taylor S. H., Silke B., Verma S. P., Sharma S. K., Jackson N. A hemodynamic comparison of verapamil, diltiazem, and amlodipine in coronary artery disease. Am Heart J. 1989 Nov;118(5 Pt 2):1105–1106. doi: 10.1016/0002-8703(89)90836-3. [DOI] [PubMed] [Google Scholar]
  25. Webster J., Robb O. J., Jeffers T. A., Scott A. K., Petrie J. C., Towler H. M. Once daily amlodipine in the treatment of mild to moderate hypertension. Br J Clin Pharmacol. 1987 Dec;24(6):713–719. doi: 10.1111/j.1365-2125.1987.tb03236.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Williams D. M., Cubeddu L. X. Amlodipine pharmacokinetics in healthy volunteers. J Clin Pharmacol. 1988 Nov;28(11):990–994. doi: 10.1002/j.1552-4604.1988.tb03119.x. [DOI] [PubMed] [Google Scholar]
  27. Zeiher A. M., Drexler H., Wollschläger H., Just H. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 1991 Feb;83(2):391–401. doi: 10.1161/01.cir.83.2.391. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES